Showing 1061-1070 of 1437 results for "".
- Study Finds High-Intensity, Parallel Beam Ultrasound-Based Skin Tightening Effective For Improving Upper Arm Skin Laxity, Crepinesshttps://modernaesthetics.com/news/study-finds-high-intensity-parallel-beam-ultrasound-based-skin-tightening-effective-for-improving-upper-arm-skin-laxity-crepiness/2483859/A study published in Dermatologic Surgery evaluated and compared the efficacy of high-intensity, parallel beam ultrasound-based skin tightening (HIUS) device with microfocused ultrasound with visualization (MFU-V) for the improvement of upper arm skin laxity and crepiness. The pr
- CollPlant Advances Light-Activated Regenerative Filler Toward Clinical Trialshttps://modernaesthetics.com/news/collplant-advances-light-activated-regenerative-filler-toward-clinical-trials/2483589/CollPlant Biotechnologies has announced the completion of a nonclinical program supporting the development of its photocurable dermal filler, which combines hyaluronic acid with a modified form of recombinant human collagen (rhCollagen). The company plans to advanc
- Study Evaluates Ready-To-Use Botox for Lateral Canthal, Glabellar Lines Treatmenthttps://modernaesthetics.com/news/study-evaluates-ready-to-use-botox-for-lateral-canthal-glabellar-lines-treatment/2483549/Newly published research in Dermatologic Surgery found liquid nivobotulinumtoxinA was effective and well-tolerated in treating moderate-to-severe lateral canthal lines (LCLs) and glabellar lines (GLs). Jean Carruthers, MD, FRCSC, FRC, co-authored the study, titled “NivobotulinumtoxinA in
- Sofwave Ultrasound Technology Remodels Collagen, Elastin, and Hyaluronic Acid in the Skinhttps://modernaesthetics.com/news/sofwave-ultrasound-technology-remodels-collagen-elastin-and-hyaluronic-acid-in-the-skin/2483484/Sofwave’s ultrasound technology is a noninvasive treatment designed to lift sagging skin on the face and neck, improve laxity on the upper arms, and reduce fine lines and wrinkles. It can also address acne scars and the short-term appearance of cellulite. The company hosted an event in New York C
- Sciton Launches Multi-Wavelength Resurfacing Laser Platformhttps://modernaesthetics.com/news/sciton-launches-multi-wavelength-resurfacing-laser-platform/2483427/Sciton, Inc. has introduced HALO® TRIBRID™, a laser platform that integrates 3 wavelengths—2940 nm, 1927 nm, and 1470 nm—into a single resurfacing device. The system combines the company’s previously distinct technologies (HALO®, MOXI™, and Erbium Resurfacing) into one handpiece, allowing provide
- Study Identifies Age-Related Collagen Changes in Vaginal Tissuehttps://modernaesthetics.com/news/study-identifies-age-related-collagen-changes-in-vaginal-tissue/2483214/A new study published in the Aesthetic Surgery Journal has identified key age-related changes in vaginal wall collagen that may contribute to the progressive degeneration of the female reproductive system. The study, titled “Age-Associated Collagen Remodeling in Vaginal Tissue: A
- Revance Brings Mepivacaine-Based Fillers to US Markethttps://modernaesthetics.com/news/revance-brings-mepivacaine-based-fillers-to-us-market/2483155/Revance has announced the US launch of the Teoxane RHA® Collection with Mepivacaine, marking a significant innovation in dermal filler formulations. The update reflects a shift in anesthetic agents used in hyaluronic acid fillers, with mepivacaine replacing lidocaine as the primary ane
- TOPICAL SKIN Launches Antioxidant Face Oilhttps://modernaesthetics.com/news/topical-skin-launches-antioxidant-face-oil/2476145/Skincare brand TOPICAL SKIN launched Phyto AOX Face Oil N°10, a plant-based facial oil developed to protect the skin from environmental damage such as pollution, UV rays, and blue light. The formula features a proprietary Exposome Defense Technology, describ
- Alma Introduces PixelPeel™ Laser Peel for Minimal-Downtime Skin Renewalhttps://modernaesthetics.com/news/alma-introduces-pixelpeel-laser-peel-for-minimal-downtime-skin-renewal/2476137/Alma has launched PixelPeel™, a new fractional laser peel treatment designed for subtle, controlled skin resurfacing with minimal recovery time. The treatment is compatible with the Alma Pixel™ and Alma Hybrid® platforms and uses the company’s MotionSync™ technology to deliver uniform exfoliation
- AMI Pharm Advances AYP-101 to Phase 3 Testing for Noninflammatory Fat Reductionhttps://modernaesthetics.com/news/ami-pharm-advances-ayp-101-to-phase-3-testing-for-noninflammatory-fat-reduction/2476093/AMI Pharm has initiated a pivotal Phase 3 clinical trial of AYP-101, an investigational injectable for the treatment of submental fat. The study will evaluate the efficacy and safety of the agent, which is designed to reduce localized fat with fewer inflammatory side effects than current therapie